NexImmune, Inc.·4

May 19, 4:16 PM ET

Trainer John 4

4 · NexImmune, Inc. · Filed May 19, 2021

Insider Transaction Report

Form 4
Period: 2021-04-08
Trainer John
Chief Financial Officer
Transactions
  • Exercise/Conversion

    Stock Option (right to buy)

    2021-04-083,432113,245 total
    Exercise: $5.17Exp: 2030-03-04Common Stock (3,432 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2021-05-083,432109,813 total
    Exercise: $5.17Exp: 2030-03-04Common Stock (3,432 underlying)
  • Exercise/Conversion

    Common Stock

    2021-05-08$5.17/sh+3,432$17,74354,906 total
  • Exercise/Conversion

    Common Stock

    2021-04-08$5.17/sh+3,432$17,74351,474 total
Footnotes (1)
  • [F1]This option vests as to 25% of the shares on January 8, 2021 with the remainder vesting in equal installments every month thereafter, beginning on January 8, 2021 and ending on January 8, 2024.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION